| EQT AB. (6/22/22). "Press Release: EQT Private Equity to Acquire SPT Labtech, a Fast-growing Laboratory Automation Player Focused on Low-volume Liquid Handling Technology for GBP 650 Million from Battery Ventures". Stockholm. |
2022-06-22 |
| AstraZeneca plc. (6/21/22). "Press Release: Eplontersen Met Co-primary and Secondary Endpoints in Interim Analysis of the NEURO-TTRansform Phase III Trial for Hereditary Transthyretin-mediated Amyloid Polyneuropathy (ATTRv-PN)". |
2022-06-21 |
| Global Bioenergies S.A.. (6/21/22). "Press Release: Global Bioenergies Secures First Order from Shell for Testing Volumes of Bio-isobutene Derivatives". Paris. |
2022-06-21 |
| Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY. |
2022-06-20 |
| Genomatica, Inc.. (6/16/22). "Press Release: Geno and Unilever Launch $120m Venture to Scale Alternative to Palm Oil and Fossil Fuels". San Diego, CA & London. |
2022-06-16 |
| Spirea Ltd.. (6/14/22). "Press Release: Spirea Raises £2.4M ($3M) to Develop Antibody Drug Conjugates in Cancer". Cambridge. |
2022-06-14 |
| High-Tech Gründerfonds Management GmbH. (6/14/22). "Press Release: Over €400 Million. New High-Tech Gründerfonds Seed Fund Exceeds Expectations". Bonn. |
2022-06-14 |
| MorphoSys AG. (6/14/22). "Press Release: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210". Planegg & South San Francisco, CA. |
2022-06-14 |
| Evonetix Ltd.. (6/13/22). "Press Release: Colin McCracken Joins Evonetix as Chief Executive Officer". |
2022-06-13 |
| Charm Therapeutics Ltd.. (6/9/22). "Press Release: Charm Therapeutics Launches with a $50 Million Series A Financing to Transform Structure-based Drug Discovery Using Its Proprietary DragonFold AI Technology". London. |
2022-06-09 |
| Relation Therapeutics Ltd.. (6/9/22). "Press Release: Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO". London. |
2022-06-09 |
| Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. |
2022-06-09 |
| Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge. |
2022-06-09 |
| Peptone Ltd.. (9/9/22). "Press Release: Peptone Closes a $40M Series-A Funding Round Led by F-Prime and Bessemer Venture Partners". London. |
2022-06-09 |
| Synklino ApS. (6/8/22). "Press Release: Synklino Completes Series A Raise of EUR 29.8 Million to Advance Clinical Trials of Its Drug Candidate for the Treatment of Cytomegalovirus (CMV)". Copenhagen. |
2022-06-08 |
| ImmunOs Therapeutics AG. (6/7/22). "Press Release: ImmunOs Therapeutics Raises $74 Million Series B Financing Round". Schlieren & Gaithersburg, MD. |
2022-06-07 |
| Transition Bio, Inc.. (6/2/22). "Press Release: Transition Bio Closes $50 Million Series A Financing to Accelerate Biomolecular Condensate Drug Discovery". Cambridge, MA & Cambridge. |
2022-06-02 |
| Transine Therapeutics Ltd.. (5/31/22). "Press Release: Transine Therapeutics Announces Final Closing of Its Seed Round at £13.7m to Accelerate Its Platform and Portfolio Development". Cambridge. |
2022-05-31 |
| GSK plc. (5/31/22). "Press Release: GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.". London. |
2022-05-31 |
| PharmEnable Ltd.. (5/30/22). "Press Release: PharmEnable Announces Multi-target Collaboration with Denali Therapeutics in Neurodegenerative Disease". Cambridge. |
2022-05-30 |
| NRG Therapeutics Ltd.. (5/30/22). "Press Release: NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease". |
2022-05-30 |
| Evotec SE. (5/30/22). "Press Release: Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand". Hamburg. |
2022-05-30 |
| UK Government (Office for Life Sciences). (5/27/22). "Press Release: UK Commits to Life Sciences Cooperation with Sweden". |
2022-05-27 |
| Advent Lfie Sciences. (5/26/22). "Press Release: Advent Life Sciences Announces Growth of Investment Team with Three Senior Appointments". London. |
2022-05-26 |
| uMotif Ltd.. (5/25/22). "Press Release: uMotif – the Patient-first Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management". London & New York, NY. |
2022-05-25 |
| Elsamogen Ltd.. (5/18/22). "Press Release: BGF, Scottish National Investment Bank and Scottish Enterprise Join Forces to Invest £8m in Aberdeen Biologics Company Elasmogen". Aberdeen. |
2022-05-18 |
| SwanBio Therapeutics, Inc.. (5/18/22). "Press Release: SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions". Philadeliphia, PA. |
2022-05-18 |
| Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. |
2022-05-18 |
| RQ Biotechnology Ltd.. (5/17/22). "Press Release: RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies". London. |
2022-05-17 |
| Thabor Therapeutics S.A.S.. (5/17/22). "Press Release: Thabor Therapeutics Appoints Jérémie Mariau as CEO". Paris. |
2022-05-17 |
| Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. |
2022-05-16 |
| Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich. |
2022-05-16 |
| Coulter Partners. (5/13/22). "Press Release: Coulter Partners Expands Its Global Team with Key Appointments and a New Office in Italy". London. |
2022-05-13 |
| Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. |
2022-05-12 |
| Artax Biopharma, Inc.. (5/11/22). "Press Release: Artax Biopharma Closes Financing to Advance Clinical Stage First-in-Class Oral Immunomodulator to Treat T Cell-Mediated Diseases". Cambridge, MA. |
2022-05-11 |
| NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL. |
2022-05-09 |
| Discovery Park Ltd.. (5/9/22). "Press Release: Discovery Park Ventures Launches to Drive Disruptive Innovation and Catalyse Regional Growth". Sandwich, Kent. |
2022-05-09 |
| Bruker Corporation. (5/9/22). "Press Release: Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets". London. |
2022-05-09 |
| Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London. |
2022-05-06 |
| Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. |
2022-05-05 |
| OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford. |
2022-04-28 |
| Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies. |
2022-04-27 |
| Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham. |
2022-04-26 |
| BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London. |
2022-04-25 |
| Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam. |
2022-04-25 |
| MitoRx Therapeutics Ltd.. (4/25/22). "Press Release: MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases". Harwell. |
2022-04-25 |
| Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin. |
2022-04-21 |
| CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. |
2022-04-21 |
| Ramarketing. (4/20/22). "Press Release: NorthEdge Invests in Leading Life Sciences Marketing Specialist Ramarketing". |
2022-04-20 |
| BioCaptiva Ltd.. (4/13/22). "Press Release: BioCaptiva Appoints Alison Williamson as Chief Financial Officer and Board Director". Edinburgh. |
2022-04-13 |
| Oxford BioTherapeutics Ltd.. (4/13/22). "Press Release: Oxford BioTherapeutics Grants Third Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to a Novel Oncology Target". Oxford & San Jose, CA. |
2022-04-13 |
| GlaxoSmithKline plc. (4/13/22). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Sierra Oncology for $1.9bn". London. |
2022-04-13 |
| Terumo Blood and Cell Technologies. (4/13/22). "Press Release: CEO Antoinette Gawin Will Serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System". Lakewood, CO. |
2022-04-13 |
| Carlyle Group, The. (4/11/22). "Press Release: Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth". New York, NY. |
2022-04-11 |
| CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. |
2022-04-11 |
| ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC. |
2022-04-07 |
| Axol Bioscience Ltd.. (4/7/22). "Press Release: Axol Bioscience Raises £3.2 Million GBP (c. $4.2 Million USD)". Cambridge. |
2022-04-07 |
| Kynos Therapeutics Ltd.. (4/7/22). "Press Release: Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor". Edinburgh. |
2022-04-07 |
| Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ. |
2022-04-06 |
| Balderton Capital. (4/6/22). "Press Release: Avi Medical Raises €50M to Put Preventative Healthcare and Digital Integration at Heart of Its Service". |
2022-04-06 |
| Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. |
2022-04-05 |
| AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". |
2022-04-04 |
| Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. |
2022-04-04 |
| Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. |
2022-04-04 |
| LGC Ltd.. (4/1/22). "Press Release: LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of NGS for High-throughput Genotyping Market in AgBio". |
2022-04-01 |
| Abzena Ltd.. (3/31/22). "Press Release: Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity". San Diego, CA. |
2022-03-31 |
| Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". |
2022-03-31 |
| CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. |
2022-03-30 |
| Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London". |
2022-03-30 |
| Argenx SE. (3/29/22). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. |
2022-03-29 |
| Core Biogenesis S.A.S.. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". |
2022-03-29 |
| XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". |
2022-03-29 |
| Sano Genetics Ltd.. (3/28/22). "Press Release: Sano Genetics Raises $11M in Funding to Accelerate Genetic Disease Research". |
2022-03-28 |
| Argenx SE. (3/23/22). "Press Release: Argenx Raises $700 Million in Gross Proceeds in a Global Offering". Breda. |
2022-03-23 |
| Closed Loop Medicine Ltd.. (3/22/22). "Press Release: Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure". Cambridge & London. |
2022-03-22 |
| Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. |
2022-03-16 |
| Adrenomed AG. (3/15/22). "Press Release: Adrenomed Supervisory Board Appoints Dr. Richard Jones as CEO". Hennigsdorf. |
2022-03-15 |
| SwanBio Therapeutics, Inc.. (3/15/22). "Press Release: FDA Grants Orphan Drug Designation to SBT101, the First Investigational AAV-Based Gene Therapy for Adrenomyeloneuropathy (AMN)". Philadeliphia, PA. |
2022-03-15 |
| SeaBeLife S.A.S.. (3/14/22). "Press Release: SeaBeLife Receives Close to €1.4M Deep Tech Financing from Bpifrance". Roscoff. |
2022-03-14 |
| Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. |
2022-03-10 |
| Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". |
2022-03-07 |
| LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf. |
2022-03-07 |
| ArrePath. (3/3/22). "Press Release: ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance". Princeton, NJ. |
2022-03-03 |
| Epsilogen Ltd.. (3/2/22). "Press Release: Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing". London. |
2022-03-02 |
| EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". |
2022-03-01 |
| PhoreMost Ltd.. (3/1/22). "Press Release: PhoreMost Promotes Dr Neil Torbett to Chief Executive Officer". Cambridge. |
2022-03-01 |
| Medigene AG. (2/25/22). "Press Release: Dr. Selwyn Ho Appointed New CEO of Medigene". Lisbon. |
2022-02-25 |
| Oncodesign S.A.. (2/24/22). "Press Release: Abzena, Alira Health and Oncodesign Launch DRIVE-Biologics to Support Access to Specialist Services from Discovery to Clinical Development for Oncology and Inflammation". Cambridge, Framingham, MA & Dijon. |
2022-02-24 |
| Complement Therapeutics Ltd.. (2/23/22). "Press Release: Complement Therapeutics Ltd Raises EUR 5 Million Seed Financing by BGV and Forbion and Appoints Dr Rafiq Hasan as CEO". London. |
2022-02-23 |
| Semarion Ltd.. (2/22/22). "Press Release: Semarion Raises £2.14m Seed Funding to Commercialise Cell Assaying Platform". Cambridge. |
2022-02-22 |
| Jeito Capital. (2/22/22). "Press Release: Jeito Capital Co-leads $65 Million Series A Financing in EyeBio". Paris. |
2022-02-22 |
| Eyebiotech Ldt.. (2/22/22). "Press Release: EyeBio Raises $65M in Series A Funding to Develop New Generation of Eye Disease Therapies". London & New York, NY. |
2022-02-22 |
| FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. |
2022-02-21 |
| Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain. |
2022-02-21 |
| Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. |
2022-02-17 |
| Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. |
2022-02-16 |
| SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. |
2022-02-16 |
| Climedo Health GmbH. (2/16/22). "Press Release: Climedo Closes €5 Million Seed Financing Round". Munich. |
2022-02-16 |
| Curve Therapeutics Ltd.. (2/16/22). "Press Release: Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform". Southampton. |
2022-02-16 |
| OxDX Ltd.. (2/15/22). "Press Release: OxDX Raises £2.6M Pre-seed Funding to Develop AI Powered Rapid Diagnostic Technology". Oxford. |
2022-02-15 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo-2019.png){kind=logo}
Date![Picture [iito] Männer Ballett 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
